Seminars in Liver Disease

Seminars in Liver Disease, with ISSN 0272-8087 and a 2026 Impact Factor of 6.5120, is a leading peer-reviewed journal dedicated to advancing the understanding and clinical management of hepatobiliary disorders. Published by Thieme Medical Publishers, this authoritative review journal provides in-depth, state-of-the-art coverage of the entire spectrum of liver disease, including viral hepatitis, non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, cirrhosis, portal hypertension, hepatocellular carcinoma, cholestatic and autoimmune liver conditions, and liver transplantation. Unlike journals that publish original research, Seminars in Liver Disease exclusively features comprehensive, invited review articles and thematic issues, each curated by expert guest editors who synthesize the latest basic science, translational research, and clinical evidence into cohesive, clinically relevant discussions. The journal also includes occasional editorials and special topic commentaries. Its primary target audience comprises hepatologists, gastroenterologists, transplant surgeons, infectious disease specialists, pathologists, and researchers seeking authoritative, up-to-date syntheses of complex topics. A notable feature is its thematic structure, with each issue focusing on a single critical topic, allowing for exhaustive and systematic exploration. The journal is not open access by default, but authors may choose open access publication options. With its impact factor consistently placing it in the top quartile (Q1) of the Gastroenterology & Hepatology category, Seminars in Liver Disease is widely regarded as a premier resource for continuing education and clinical reference, offering unparalleled depth and credibility in a rapidly evolving field.